BAY-1797
BAY-1797 is a potent and selective oral P2X4 receptor antagonist (human IC50 = 211 nM) with demonstrated anti-nociceptive and anti-inflammatory properties in preclinical research. It shows high selectivity over other P2X family channels, making it a valuable tool for investigating neuropathic pain and inflammatory pathways in both in vitro and in vivo studies.
Product Specifications
CAS Number
2055602-83-8
Product Name Alternative
Complete, channel, Adjuvant, CFA, BAY 1797, BAY1797, BAY-1797, anti-nociceptive, anti-inflammatory, inflamed, inhibit, ion, paw, Inhibitor, human P2X7, human P2X1, human P2X23, human P2X3, human P2X4, Freund's, selective, P2X, P2X Receptor, P2XRs, P2XReceptor
Field of Research
Immunology & Inflammation
Purity
>98%
Bioactivity
P2X4 antagonist (selective)
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
NS (=O) (=O) c1cc (NC (=O) Cc2ccccc2) ccc1Oc1cccc (Cl) c1
Molecular Formula
C20H17ClN2O4S
Molecular Weight
416.9
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N-[4- (3-Chlorophenoxy) -3-sulfamoylphenyl]-2-phenylacetamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog